The present disclosure relates to novel sulfonylurea and sulfonyl thiourea compounds and related compounds and their use in treating a disease or condition responsive to modulation of cytokines such as IL-1β and IL-18, modulation of NLRP3 or inhibition of the activation of NLRP3 or related components of the inflammatory process.
本公开涉及新型磺酰
脲和磺酰
硫脲化合物以及相关化合物,以及它们在治疗对细胞因子如IL-1β和IL-18的调节敏感的疾病或状况中的应用,调节NLRP3或抑制NLRP3或相关炎症过程组分的激活。